Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 348
- Registration Number
- NCT01915823
- Locations
- 🇺🇸
Clinical Research Atlanta, Atlanta, Georgia, United States
🇺🇸Little Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
🇺🇸Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: 205.5 mcg of azelastine hydrochlorideDrug: 137 mcg of azelastine hydrochloride
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 191
- Registration Number
- NCT01880840
- Locations
- 🇺🇸
Texas Allergy Research Center, Dallas, Texas, United States
🇺🇸Paul H Ratner,MD, San Antonio, Texas, United States
🇺🇸Live Oak Allergy and Asthma Clinic, San Antonio, Texas, United States
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 405
- Registration Number
- NCT01794741
- Locations
- 🇺🇸
West Coast Clinical Trials, Costa Mesa, California, United States
🇺🇸Allergy Associates Medical Group Inc, San Diego, California, United States
🇺🇸Southern California Research, Mission Viejo, California, United States
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
- Conditions
- Herpes Labialis
- Interventions
- Drug: acyclovir/hydrocortisone cream
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 54
- Registration Number
- NCT01574612
- Locations
- 🇺🇸
Altus Rsearch,INC, West Palm Beach, Florida, United States
🇺🇸Provident Clincal Research, Addison, Illinois, United States
🇺🇸MCS Clinical Trials, Los Angeles, California, United States
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 617
- Registration Number
- NCT01368445
- Locations
- 🇺🇸
AARA Research Center, Dallas, Texas, United States
🇺🇸Allergy Medical Group, Roseville, California, United States
🇺🇸Valley Clinical Research Center, Easton, Pennsylvania, United States
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 489
- Registration Number
- NCT01018862
- Locations
- 🇺🇸
Chesapeake Clinical Research, Inc, Baltimore, Maryland, United States
🇺🇸Intermountain Clinical Research, Draper, Utah, United States
🇺🇸Colorado Allergy and Asthma Centers, PC, Denver, Colorado, United States
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: PlaceboDrug: azelastineHcl
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 1791
- Registration Number
- NCT00883168
- Locations
- 🇺🇸
Princeton Center for Clinical Research, Skillman, New Jersey, United States
🇺🇸Clinical Research Institute of Southern Oregon, PC, Medford, Oregon, United States
🇺🇸Allergy and Clinical Immunology Associates, Pittsburgh, Pennsylvania, United States
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 506
- Registration Number
- NCT00824473
- Locations
- 🇺🇸
Allergy and Asthma Center of Austin, Austin, Texas, United States
🇺🇸Allergy and Asthma Associates, Austin, Texas, United States
🇺🇸Sylvana Research Associates, San Antonio, Texas, United States
Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
- Conditions
- Chronic Allergic RhinitisNonallergic Rhinitis
- Interventions
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 862
- Registration Number
- NCT00783432
- Locations
- 🇺🇸
Meda Clinical Trials Contact Center, Somerset, New Jersey, United States
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-08-25
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 776
- Registration Number
- NCT00740792
- Locations
- 🇺🇸
Allergy, Asthma and Immunology Associates, Scottsdale, Arizona, United States
🇺🇸Northeast Medical Research Associates, North Dartmouth, Massachusetts, United States
🇺🇸Princeton Center for Clinical Research, Skillman, New Jersey, United States